Pacific Biosciences Of California (PACB) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | -5.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.04% |
| Dec 31, 2025 | 38.23% |
| Sep 30, 2025 | 58.32% |
| Jun 30, 2025 | 46.31% |
| Mar 31, 2025 | 42.88% |
| Dec 31, 2024 | 45.85% |
| Sep 30, 2024 | 32.32% |
| Jun 30, 2024 | -26.66% |
| Mar 31, 2024 | 19.16% |
| Dec 31, 2023 | 8.99% |
| Sep 30, 2023 | 1.83% |
| Jun 30, 2023 | 31.86% |
| Mar 31, 2023 | -19.05% |
| Dec 31, 2022 | -89.49% |
| Jun 30, 2022 | -273.72% |
| Mar 31, 2022 | -251.70% |
| Dec 31, 2021 | -141.10% |
| Jun 30, 2021 | 28.32% |
| Mar 31, 2021 | -131.24% |
| Dec 31, 2020 | 21.78% |
| Sep 30, 2020 | -1.41% |
| Jun 30, 2020 | -32.67% |
| Mar 31, 2020 | 383.24% |
| Dec 31, 2019 | 3.79% |
| Sep 30, 2019 | -26.75% |
| Jun 30, 2019 | -14.63% |
| Mar 31, 2019 | -38.97% |
| Dec 31, 2018 | 10.43% |
| Sep 30, 2018 | 32.35% |
| Jun 30, 2018 | 2.49% |
| Mar 31, 2018 | 1.15% |
| Dec 31, 2017 | -36.70% |
| Sep 30, 2017 | -16.05% |
| Jun 30, 2017 | 25.02% |
| Mar 31, 2017 | 6.68% |
| Dec 31, 2016 | -876.88% |
| Sep 30, 2016 | -12.00% |
| Jun 30, 2016 | -156.63% |
| Mar 31, 2016 | 15.85% |
| Dec 31, 2015 | 89.95% |
| Sep 30, 2015 | -152.59% |
| Jun 30, 2015 | 40.01% |
| Mar 31, 2015 | -47.18% |
| Dec 31, 2014 | -7.89% |
| Sep 30, 2014 | -134.74% |
| Jun 30, 2014 | 15.59% |
| Mar 31, 2014 | 6.37% |
| Dec 31, 2013 | 21.36% |
| Sep 30, 2013 | 202.00% |
| Jun 30, 2013 | 30.81% |
| Mar 31, 2013 | -1.48% |
| Dec 31, 2012 | -15.13% |
| Sep 30, 2012 | 30.56% |
| Jun 30, 2012 | 31.06% |
| Mar 31, 2012 | 49.61% |
| Dec 31, 2011 | 59.75% |
| Sep 30, 2011 | 24.08% |